Align Tech (ALGN) Stock Forecast & Price Target

Compare

3,212 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

ALGN Analyst Ratings

Moderate Buy

9 Buy

3 Hold

1 Sell

Based on 13 analysts giving stock ratings to

Align

Tech

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

ALGN Stock 12 Month Forecast

Average Price Target

$231.91

▲(23.02%Upside)

Based on 13 Wall Street analysts offering 12 month price targets for Align Tech in the last 3 months. The average price target is $231.91 with a high forecast of $275.00 and a low forecast of $170.00. The average price target represents a 23.02% change from the last price of $188.52.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"157":"$157","276":"$276","186.75":"$186.8","216.5":"$216.5","246.25":"$246.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":275,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$275.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":231.91,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$231.91</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":170,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$170.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[157,186.75,216.5,246.25,276],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Sep<br/>2024","6":"Dec<br/>2024","9":"Mar<br/>2025","12":"Jun<br/>2025","25":"Jun<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,178.51,185.9323076923077,193.35461538461539,200.77692307692308,208.19923076923075,215.62153846153845,223.04384615384615,230.46615384615384,237.88846153846154,245.3107692307692,252.7330769230769,260.1553846153846,267.5776923076923,{"y":275,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,178.51,182.6176923076923,186.7253846153846,190.83307692307693,194.94076923076923,199.04846153846154,203.15615384615384,207.26384615384615,211.37153846153845,215.47923076923075,219.58692307692309,223.6946153846154,227.8023076923077,{"y":231.91,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,178.51,177.8553846153846,177.20076923076923,176.54615384615383,175.89153846153846,175.23692307692306,174.5823076923077,173.9276923076923,173.27307692307693,172.61846153846153,171.96384615384616,171.30923076923077,170.6546153846154,{"y":170,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":257.21,"date":1717200000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":238.64,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":228.33,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":237.22,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":245.35,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":208.58,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":234.14,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":208.51,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":219.11,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":187.03,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":158.08,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":176.74,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":178.51,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$275.00

Average Price Target$231.91

Lowest Price Target$170.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

TipRanks AITipRanks

Not Ranked

TipRanks

$201

Buy

6.62%

Upside

Reiterated

06/21/25

Align Tech's strong financial health and strategic initiatives in product expansion and market reach are key strengths. However, challenges in valuation and mixed technical indicators weigh on the overall score. The positive impact of the stock buyback program provides additional support to the stock's outlook.

Michael ChernyLeerink Partners

Leerink Partners

$246

Buy

30.49%

Upside

Reiterated

06/18/25

Analysts Conflicted on These Healthcare Names: Align Tech (NASDAQ: ALGN), Nurix Therapeutics (NASDAQ: NRIX) and Thermo Fisher (NYSE: TMO)

Jason BednarPiper Sandler

Piper Sandler

$250

Buy

32.61%

Upside

Reiterated

06/18/25

Piper Sandler Reaffirms Their Buy Rating on Align Tech (ALGN)

Elizabeth Anderson CFAEvercore ISI

Evercore ISI

$200

Buy

6.09%

Upside

Reiterated

06/11/25

Align Tech (ALGN) Receives a Buy from Evercore ISI

Michael SarconeJefferies

Jefferies

$260

Buy

37.92%

Upside

Reiterated

06/05/25

Align Tech's Strategic Innovations and Geographic Expansion Drive Buy Rating

Jonathan BlockStifel Nicolaus

Stifel Nicolaus

$285→$275

Buy

45.87%

Upside

Reiterated

05/30/25

Analysts' Top Healthcare Picks: Align Tech (ALGN), Eli Lilly & Co (LLY)

Erin WrightMorgan Stanley

Morgan Stanley

$249

Buy

32.08%

Upside

Reiterated

05/07/25

Align Technology: Strategic Innovations and Realistic Financial Targets Justify Buy Rating

Brandon VazquezWilliam Blair

William Blair

―

Buy

―

Reiterated

05/07/25

Align Tech's Strategic Growth and Market Expansion: A Buy Recommendation

Michael RyskinBank of America Securities

Bank of America Securities

$195

Sell

3.44%

Upside

Reiterated

05/07/25

Cautious Outlook on Align Tech: Sell Rating Amidst Market Challenges and Revised Growth Targets

Vik ChopraWells Fargo

Wells Fargo

$246

Buy

30.49%

Upside

Reiterated

05/06/25

We expect to get add'l details as the day progresses. 2026-2028...ALGN provided guidance of Clear Aligner volume growth 5-15%; Revenue growth of +5-15%; Gross margins of 71-73%; Operating margins of 23-25%; and FCF growth of 18-23%. The expert we spoke to last week indicated that 7-10% top- line growth over the next couple of years would be reasonable. Generally, investors were looking for top-line growth targets of ~5-10%.

David SaxonNeedham

Needham

―

Hold

―

Reiterated

05/01/25

Align Tech Hold Rating: Balancing Positive Q1 Results with Macroeconomic Concerns

Steven ValiquetteMizuho Securities

Mizuho Securities

$250→$245

Buy

29.96%

Upside

Reiterated

04/29/25

Align Technology price target lowered to $245 from $250 at MizuhoAlign Technology price target lowered to $245 from $250 at Mizuho

Sidharth SahooHSBC

HSBC

$290→$170

Hold

-9.82%

Downside

Downgraded

04/25/25

Align Technology downgraded to Hold from Buy at HSBCAlign Technology downgraded to Hold from Buy at HSBC

Kevin CaliendoUBS

UBS

$240→$215

Hold

14.05%

Upside

Reiterated

04/24/25

Align Technology price target lowered to $215 from $240 at UBSAlign Technology price target lowered to $215 from $240 at UBS

Jeff JohnsonRobert W. Baird

Robert W. Baird

$276→$250

Buy

32.61%

Upside

Reiterated

02/06/25

Align Technology price target lowered to $250 from $276 at BairdAlign Technology price target lowered to $250 from $276 at Baird

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

TipRanks AITipRanks

Not Ranked

TipRanks

$201

Buy

6.62%

Upside

Reiterated

06/21/25

Michael ChernyLeerink Partners

Leerink Partners

$246

Buy

30.49%

Upside

Reiterated

06/18/25

Analysts Conflicted on These Healthcare Names: Align Tech (NASDAQ: ALGN), Nurix Therapeutics (NASDAQ: NRIX) and Thermo Fisher (NYSE: TMO)

Jason BednarPiper Sandler

Piper Sandler

$250

Buy

32.61%

Upside

Reiterated

06/18/25

Piper Sandler Reaffirms Their Buy Rating on Align Tech (ALGN)

Elizabeth Anderson CFAEvercore ISI

Evercore ISI

$200

Buy

6.09%

Upside

Reiterated

06/11/25

Align Tech (ALGN) Receives a Buy from Evercore ISI

Michael SarconeJefferies

Jefferies

$260

Buy

37.92%

Upside

Reiterated

06/05/25

Align Tech's Strategic Innovations and Geographic Expansion Drive Buy Rating

Jonathan BlockStifel Nicolaus

Stifel Nicolaus

$285→$275

Buy

45.87%

Upside

Reiterated

05/30/25

Analysts' Top Healthcare Picks: Align Tech (ALGN), Eli Lilly & Co (LLY)

Erin WrightMorgan Stanley

Morgan Stanley

$249

Buy

32.08%

Upside

Reiterated

05/07/25

Align Technology: Strategic Innovations and Realistic Financial Targets Justify Buy Rating

Brandon VazquezWilliam Blair

William Blair

―

Buy

―

Reiterated

05/07/25

Align Tech's Strategic Growth and Market Expansion: A Buy Recommendation

Michael RyskinBank of America Securities

Bank of America Securities

$195

Sell

3.44%

Upside

Reiterated

05/07/25

Cautious Outlook on Align Tech: Sell Rating Amidst Market Challenges and Revised Growth Targets

Vik ChopraWells Fargo

Wells Fargo

$246

Buy

30.49%

Upside

Reiterated

05/06/25

David SaxonNeedham

Needham

―

Hold

―

Reiterated

05/01/25

Align Tech Hold Rating: Balancing Positive Q1 Results with Macroeconomic Concerns

Steven ValiquetteMizuho Securities

Mizuho Securities

$250→$245

Buy

29.96%

Upside

Reiterated

04/29/25

Align Technology price target lowered to $245 from $250 at MizuhoAlign Technology price target lowered to $245 from $250 at Mizuho

Sidharth SahooHSBC

HSBC

$290→$170

Hold

-9.82%

Downside

Downgraded

04/25/25

Align Technology downgraded to Hold from Buy at HSBCAlign Technology downgraded to Hold from Buy at HSBC

Kevin CaliendoUBS

UBS

$240→$215

Hold

14.05%

Upside

Reiterated

04/24/25

Align Technology price target lowered to $215 from $240 at UBSAlign Technology price target lowered to $215 from $240 at UBS

Jeff JohnsonRobert W. Baird

Robert W. Baird

$276→$250

Buy

32.61%

Upside

Reiterated

02/06/25

Align Technology price target lowered to $250 from $276 at BairdAlign Technology price target lowered to $250 from $276 at Baird

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Align Tech

1 Month

xxx

Success Rate

20/36 ratings generated profit

Average Return

+1.25%

reiterated a xxx

rating 2 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 55.56% of your transactions generating a profit, with an average return of +1.25% per trade.

3 Months

xxx

Success Rate

22/36 ratings generated profit

Average Return

+7.68%

reiterated a xxx

rating 2 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 61.11% of your transactions generating a profit, with an average return of +7.68% per trade.

1 Year

Erin WrightMorgan Stanley

Success Rate

20/36 ratings generated profit

Average Return

+18.68%

reiterated a buy rating 2 months ago

Copying Erin Wright's trades and holding each position for 1 Year would result in 55.56% of your transactions generating a profit, with an average return of +18.68% per trade.

2 Years

xxx

Success Rate

18/36 ratings generated profit

Average Return

+20.33%

reiterated a xxx

rating 2 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 50.00% of your transactions generating a profit, with an average return of +20.33% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

ALGN Analyst Recommendation Trends

Rating

Feb 25

Mar 25

Apr 25

May 25

Jun 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, ALGN has received 27 Buy Ratings, 3 Hold Ratings, and 3 Sell Ratings. ALGN average Analyst price target in the past 3 months is 231.91.

Each month's total comprises the sum of three months' worth of ratings.

ALGN Financial Forecast

ALGN Earnings Forecast

Next quarter’s earnings estimate for ALGN is $2.57 with a range of $2.54 to $2.62. The previous quarter’s EPS was $2.13. ALGN beat its EPS estimate 75.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.16% of the time in the same period. In the last calendar year ALGN has Outperformed its overall industry.

ALGN Sales Forecast

Next quarter’s sales forecast for ALGN is $1.06B with a range of $1.04B to $1.07B. The previous quarter’s sales results were $979.26M. ALGN beat its sales estimates 25.00% of the time in past 12 months, while its overall industry beat sales estimates 47.53% of the time in the same period. In the last calendar year ALGN has Outperformed its overall industry.

ALGN Stock Forecast FAQ

What is ALGN’s average 12-month price target, according to analysts?

Based on analyst ratings, Align Tech’s 12-month average price target is 231.91.

What is ALGN’s upside potential, based on the analysts’ average price target?

Align Tech has 23.02% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is ALGN a Buy, Sell or Hold?

Align Tech has a consensus rating of Moderate Buy which is based on 9 buy ratings, 3 hold ratings and 1 sell ratings.

What is Align Tech’s price target?

The average price target for Align Tech is 231.91. This is based on 13 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $275.00 ,the lowest forecast is $170.00. The average price target represents 23.02% Increase from the current price of $188.52.

What do analysts say about Align Tech?

Align Tech’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 13 Wall Streets Analysts.

How can I buy shares of ALGN?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

Align Tech (ALGN) Stock Forecast & Price Target

ALGN Analyst Ratings

ALGN Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Align Tech

ALGN Analyst Recommendation Trends

ALGN Financial Forecast

ALGN Earnings Forecast

ALGN Sales Forecast

ALGN Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts